Neurent Medical is dedicated to developing highly innovative non-surgical interventions that treat chronic inflammatory Sino-Nasal diseases. The privately held, venture backed company is based in Galway Ireland. Neurent Medical was founded by CEO Brian Shields and CTO David Townley, culminating from their work at the BioInnovate Ireland program at the National University, Galway.

Leadership Team and Board of Directors
Brian Shields
Co-founder & CEO
Board Member
 
 
View Bio
David Townley
Co-founder & CTO
Board Member

 
 
View Bio
Declan Daly
Chief Financial Officer
 
 
 
View Bio
Karen Peterson
VP of Clinical, Regulatory & Quality
 
 
View Bio
Prasad Nalluri
VP Strategic Marketing
 
 
 
View Bio
Brent Shreiner
VP Sales
 
 
 
View Bio
Mark Fletcher
Chairman of the Board
Former President, Medtronic Surgical Technologies
View Bio
Justin Lynch
Board Member
Partner & CFO,
Fountain Healthcare Partners
View Bio
Eamon Brady
Board Member
CEO,
WhiteSwell

 
View Bio
Drew Burdon
Board Member
LSP

 
View Bio
Gerry Maguire
General Partner
Atlantic Bridge

 
View Bio
SOME OF OUR
Recent News

Stay up to date with the latest news from Neurent Medical

Neurent Medical Receives FDA Clearance for NEUROMARK, a Novel Multi-Point Nerve Disruption Treatment for Chronic Rhinitis

18th November 2021

Press release about FDA Clearance

Neurent Medical Expands Leadership Team to Support Advancement of In-Office Chronic Rhinitis Treatment

24th June 2021

Press release about Leadership Team expansion

Neurent Medical Closes $25 Million Series B Funding to Advance Innovative Chronic Rhinitis Treatment

20th January 2021

Press release about the $25 Million Series B Funding.